Screening of coexpression genes of immune cells in breast cancer tissues

Yuan-Yuan Zhang,Yi-Min Gan

DOI: https://doi.org/10.1097/md.0000000000036211

IF: 1.6

2024-01-11

Medicine

Abstract:Breast cancer is one of the most common malignant tumors in women. More than half of them are at the advanced stage of diagnosis. [ 1 , 2 ] Breast cancer has the highest mortality rate among women younger than 45 years old. [ 3 , 4 ] Breast cancer is prone to distant metastasis, including transferring [ 4 , 5 ] to the lung, liver, kidney and bone. Treating breast cancer is complex and expensive and requires long-term follow-up. [ 6–9 ] At present, breast cancer treatment cannot achieve the desired effect. Therefore, patients need to face a high recurrence rate and drug resistance. [ 10 ] With the development of medical technology, breast cancer treatment has gradually been systematized. [ 11 ] Recently, immunotherapy has provided new ideas for treating breast cancer, especially for breast cancer in an advanced stage. [ 12 ] For example, previous research suggested potential targets of immune checkpoint therapy, which included proteins such as cytotoxic T lymphocyte-associated antigen 4 and programmed cell death ligand 1 in breast cancer. [ 13 ]

medicine, general & internal